Oruka Therapeutics files to sell 39.43M shares of common stock for holders
Source: SeekingAlpha
2025-10-03 17:27:55 ET
More on Oruka Therapeutics
- Oruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trial
- Seeking Alpha’s Quant Rating on Oruka Therapeutics
- Historical earnings data for Oruka Therapeutics
- Financial information for Oruka Therapeutics
Read the full article on Seeking Alpha
For further details see:
Oruka Therapeutics files to sell 39.43M shares of common stock for holders
Oruka Therapeutics Inc.
NASDAQ: ORKA
ORKA Trading
-3.79% G/L:
$32.74 Last:
45,575 Volume:
$34 Open:
ORKA Latest News
ORKA Stock Data
$1,591,695,548
36,456,993
2.59%
56
N/A
Biotechnology & Life Sciences
Healthcare
US
Menlo Park
